CD4 and rheumatoid arthritis: In conclusion, our results demonstrated that an increased percentage of CD4+CD161+ T cells and a decreased percentage of CD4−CD8−CD161+ T cells are present in SF of RA patients and correlate well with disease activity indices, and thus, may be involved in the local inflammation and clinical outcome of RA.